SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $152 | -47.9% | 64,201 | +5.2% | 0.00% | – |
Q2 2023 | $292 | -55.2% | 61,020 | -47.0% | 0.00% | -100.0% |
Q1 2023 | $652 | +2314.8% | 115,100 | +2228.5% | 0.00% | – |
Q4 2022 | $27 | -100.0% | 4,943 | -43.9% | 0.00% | – |
Q4 2021 | $73,000 | -94.8% | 8,818 | -85.8% | 0.00% | -100.0% |
Q3 2021 | $1,404,000 | +19.5% | 62,164 | +26.1% | 0.00% | 0.0% |
Q2 2021 | $1,175,000 | +74.9% | 49,282 | +51.0% | 0.00% | 0.0% |
Q1 2021 | $672,000 | +147.1% | 32,641 | +193.5% | 0.00% | – |
Q4 2020 | $272,000 | -73.9% | 11,121 | -69.8% | 0.00% | -100.0% |
Q3 2020 | $1,042,000 | +25950.0% | 36,826 | +2539.9% | 0.00% | – |
Q4 2019 | $4,000 | -86.2% | 1,395 | -84.7% | 0.00% | – |
Q2 2019 | $29,000 | +123.1% | 9,100 | +601.1% | 0.00% | -100.0% |
Q4 2017 | $13,000 | -95.1% | 1,298 | -92.2% | 0.00% | -90.9% |
Q3 2017 | $267,000 | +403.8% | 16,678 | +280.2% | 0.01% | +175.0% |
Q3 2016 | $53,000 | – | 4,387 | +19840.9% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 22 | -86.5% | 0.00% | – |
Q3 2015 | $4,000 | – | 163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
Knott David M Jr | 70,000 | $167 | 0.06% |
XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |